On Thursday, the U.S. Centers for Disease Control and Prevention (CDC) recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N) shots, and said Americans can choose a different shot from their original inoculation as a booster.CDC director
US Pharma giant Pfizer is in the final stages of an agreement with India to supply anti-COVID-19 vaccines, CEO Dr Albert Bourla said on Tuesday, observing that the domestically manufactured vaccines would be the backbone of vaccinating the Indian people. Addressing the 15th edition of
Asserting that India is on track to vaccinate its entire adult population by December, top officials sources on Monday said a blueprint is in place to ensure a total supply of 187.2 crore doses by the year-end that would be enough for the country’s 94
The World Health Organisation (WHO) said on Tuesday that it has approved China’s second COVID-19 vaccine ‘Sinovac’ for emergency use listing.“WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for
Vaccine, being a biological product, takes time for harvesting and quality testing and this cannot be done overnight to ensure a safe product, the Union Health Ministry said on Friday.The ministry said Government of India, through the National Expert Group on Vaccine Administration for COVID-19
The government is examining Pfizer’s request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) V K Paul said on Thursday.At a press conference, Paul said, “Yes we are engaged with Pfizer and they
